Abstract
The discovery and development of the main classes of antimicrobials used in therapy of humans and animals has been recently overviewed [Citation1]. The introduction of antimicrobials into clinical practice fundamentally changed the way that microbial infections are controlled and managed and has contributed to a significant decrease in morbidity and mortality rates caused by microbial infections on mankind. Despite the overall success of antimicrobials, their efficacy and reliability has been severely compromised in recent years, due to the emergence and spread of antimicrobial resistance (AMR) among pathogens [Citation2].
| Original language | English |
|---|---|
| Pages (from-to) | 983-985 |
| Number of pages | 3 |
| Journal | Expert Opinion on Drug Discovery |
| Volume | 13 |
| Issue number | 11 |
| Early online date | 29 Aug 2018 |
| DOIs | |
| Publication status | Published - 2 Nov 2018 |
Funding
This manuscript was not funded.
Keywords
- antimicrobial resistance
- Antimicrobials
- novel antimicrobials
Fingerprint
Dive into the research topics of 'Antimicrobial drug discovery: lessons of history and future strategies'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS